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The treatment of diabetes mellitus by transplantation of isolated pancreatic 
islets is an approach that remains the subject of research by a large number of 
investigators throughout the world. A crucial requirement for the success of 
this enterprise is the ability to prepare viable isolated islets in adequate quan-
tity. Over the years numerous descriptions of procedures for islet isolation 
from the pancreas of experimental animals and of man have been advanced; 
each claiming to be an improvement on previous methods. Indeed, there cer-
tainly have been advances, although few techniques live up to the claims that 
are made in their support Part of the problem is the generally poor methodology 
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used to assess the outcome of islet isolation techniques. For a scientifIC subject 
to advance it is necessary to have accurate methods of measurements, for oth-
erwise comparisons of the results obtained by different investigators are im-
possible. 
The problem is less for techniques described for isolation of islets from the 
pancreas of small animals such as the rodent, where it is possible to actually 
count the number of islets retrieved, although even here many errors are pos-
sible and have undoubtedly occurred. Recently there have been reports of 
increasingly successful islet isolation from the pancreas of larger mammals 
and man, where the yields obtained have been too large to count directly. This 
progress has accentuated the need for the development of precise and reprod-
ucible techniques for assessing islet yield in use in different laboratories. The 
variety of quantitative assessment techniques has made meaningful compari-
son of results very difflcult and the situation is further compounded by similar 
diffIculties facing such issues as the purity and viability of the preparation. 
With the above diffICulties in mind, a workshop was organized at the 2nd 
Congress on Pancreas and Islet Transplantation to develop a consensus on 
criteria for assessment of islets isolated from the pancreas of large mammals, 
including humans. Both quantitative and qualitative criteria were discussed, 
and the discussion focused on the main topics of assessment of islet number 
and volume, the purity of the preparation, morphologic integrity, and test of 
islet viability in vitro and in vivo. 
Islet number, volume, and purity - The sampling technique represents a criti-
cal factor that could affect the results of an islet count as well as insulin con-
tent from any islet preparation. Since islets settle rapidly in any container, care 
must be taken to properly suspend the preparation before sampling to ensure 
a representative sample. It is preferable also to collect multiple samples to 
minimize counting errors (e.g. 5 aliquots of 50 fLl after suspension of the islet 
preparation in a 200 ml flask). If the preparation is not needed for transplata-
tion it is also wise to collect a larger sample that may be more representative 
(e.g. 1 ml from 200 ml islet suspension). 
Even though experience facilitates the ability to distinguish an islet from a 
clump of exocrine cells, ganglia, lymph nodes or so-called 'membrane balls' at 
the light microscopical level, it has been uniformly recommended that a spe-
cifIC stain for immediate detection of islet tissue should be used in any sample. 
For this purpose dithizone (DTZ) seems to be the most appropriate. An easy 
and rapid way to stain islets is to add few drops of a DTZ solution [prepared as 
follows: add 50 mg DTZ to 5 ml dimethylsulfoxide (DMSO), stock solution, and 
dilute 1 ml of this solution with 20 ml of Hank's with 2% fetal calf serum (FCS) 
to a sample contained in a petri dish]. The solution must be freshly prepared 
and fIltered before use. After staining the sample it is possible to count the 
islets that will appear red as previously described 20. Since islet volume is ap-
proximately proportional to the cube of the islet radius, it is crucial to divide 
the islets into diameter classes. For this purpose it is possible to use a cali-
brated grid in the eyepiece of the phase contrast microscope 24. As a matter of 
routine, most workers use 50 fL diameter range increments without considering 
particles smaller than 50 fL, since their contribution to the total volume of the 
preparation would not be signiflcant. Tab. 1 indicates the mean volume for 
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each diameter class and the relative conversion factor into islets of 150 [1. di-
ameter. These factors make it possible to convert the total islet number from 
any preparation into equivalent islet number (EIN). In place of EIN, the total 
islet volume of the fmal preparation can also be estimated. Nevertheless, EIN 
can be useful for those who are not familiar with conversion of the volume of 
a preparation into islet number. As a general rule, the more descriptive the 
results of an isolation are, the better their interpretation. The potential use of 
automated methods using computerized imaging analyzers appears to be an 
attractive alternative to visual methods and may provide a more objective and 
standard quantitative evaluation. Although this technology appears very prom-
ising, it is expensive and judged to be too premature to propose it as a general 
standard. 
Although many approaches for determination of islet purity have been 
proposed, including insulin/amylase ratio and algebric equations, each has 
inherent problems that result in assessment variabilities that are not easily 
controlled. Again, it is possible that the automatic methods employing either 
specifiC stains or highly specifiC monoclonal antibodies will be used ultimately, 
but for now most investigators use the dithizone stain described earlier as an 
easy method to roughly estimate the approximate degree of purity of the islets 
in any preparation. 
Morphological assessment - The appropriate morphological assessment of iso-
lated islet preparations should include three different aspects: confirmation of 
islet identifICation, assessment of the morphological integrity of the isolated 
and purified islets as well as the assessment of the purity of the islet prepara-
tion. 
While several recent papers have focused on the critical assessment of 
number, volume, purity and function of isolated islets, there have been few 
studies that have explicitly focused on the detailed morphological investigation 
of isolated islets 35,39. 
Many studies reporting improved methods for islet isolation lack adequate 
information demonstrating that the structures identified as islets by stereomi-
croscopy were, in fact, islets. Although dithizone staining20 of wet islet prepara-
tions is to be seen as a fairly specifiC method of islet verification (e.g. bovine 
islet diameter mean volume conversion into islets 
range (fl) (fl') of 150 fl diameter 
50-100 294,525 n/ 6.00 
100-J50 1,145,373 n/ 1.50 
150-200 2,977,968 nX 1.7 
200-250 6,185,010 nX 3.5 
250-300 11,159,198 nX 6.3 
300-350 18,293,231 nxl0A 
350-400 27,979,808 nxl5.S 
Tab. 1 - Determination of islet volume for each 50 fJ. diameter range and relative conversion 
into equivalent number of islets with a diameter of 150 [.I.. 
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islets remain unstained after adding dithizone), the accurate identifICation of 
islets by stereomicroscopy should therefore be confIrmed by subsequent light 
microscopic examination demonstrating positive aldehyde-fuchsin staining or 
immunoperoxidase insulin-labeling of B-cells or, on a more complex level, by 
electron microscopic evaluation showing characteristic granules within endo-
crine cells. Another method that permits rapid, accurate, and simple confIrma-
tion of islet identifIcation v.r:ithin 3-4h is by double antibody indirect immuno-
fluorescence of cryostat sections, in which a guinea pig unlabeled insulin an-
tibody is reacted, in a second step, by application of fluorescein-labeled goat-
antiguinea pig immunoglobulin. The accurate identifICation of islets employ-
ing either immunocytochemical staining or electron microscopic examination 
should be an essential inclusion in every newly reported method of islet isola-
tion and purifICation. 
After islet identifIcation has been convincingly established, it is important 
to evaluate the morphological integrity of the islets that were isolated. Many 
of the available viability tests fail to exclude the possibility that the islet, as a 
microorgan with a subtle and complex organization, has been seriously in-
jured. Surprisingly little is known about the effects of pancreas procurement, 
islet isolation, islet purifICation and islet banking procedures on the morpho-
logical integrity of the islet tissue 1, II, 17,23,25,26,30,32,43,44. The relative paucity of 
studies dealing with the morphology of isolated islets probably reflects a com-
placent attitude that developed early after experience indicated that isolated 
rodent islet tissue was well preserved and that islet tissue appeared to be 
much more resistant to damage during the isolation procedure than acinar 
cells. 
However, more recent studies have emphasized meYor differences in the 
structure and integrity of islets isolated from rodents and dogs 1, indicating 
that the isolation procedures applied in large animals disrupt the vascular, 
neural and paracrine relationship components of the native islets, potentially 
affecting important functional interrelationships between islet cell popula-
tions. ALEJANDRO et a1. 1 demonstrated that while rodent islets remained com-
pact after isolation with their margins predominantly smooth and tightly 
epithelialized, isolated canine islets were, in contrast, frequently fragmented 
and the endocrine cells appeared to be loosely adherent to each other. This 
observation particularly applies to islets retrieved from the porcine pancreas. 
RICORDI et a1. 30 pointed out that the loose organization of islets within the pig 
pancreas probably accounts for their marked fragility and rapid dissociation 
into single cells during the isolation procedure. It is interesting to note in this 
context that one can be surprised by discrepancies between the seemingly 
intact stereo microscopical appearance of isolated porcine islets and the ab-
normal morphological features of the same islets in paraffIn or semithin sec-
tions. It is highly desirable, therefore, that newly published studies on islet 
isolation and purifIcation include a detailed analysis of the morphological 
features, In particular, attention should be paid to the signals of traumatic 
damage such as irregularly shaped or fragmented islets, discontinuous 
plasma membranes, mitochondrial swelling with inner membrane disruption, 
cytoplasmic vacuolation due to massive dilatation of cisternae of the endo-
plasmic reticulum, reduction of cytoplasmic and nuclear matrix density or 
pyknotic nuclei. 
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In addition, it is important to detennine whether the individual islet cells 
are randomly scattered and loosely adherent or whether they are still organ-
ized in relation to each other corresponding to the nonnal islet architecture 
within the native pancreas. 
Another signifIcant issue is whether the connective and vascular tissue 
within the islets has been preserved and the isolated islets are free or are 
surrounded by connective and exocrine tissue. In this context, scanning elec-
tron microscopy15.46 as well as confocal microscopy, a recently described tech-
nique for analyzing the three-dimensional structure of isolated islets7, will be 
considered as additional approaches to study surface changes of isolated 
islets. 
It is important for co-workers in the fIeld to examine representative photo-
micrographs of stained paraffIn or semithin sections so as to enable them to 
independently evaluate the extent of the purification (ratio of islet to non-islet 
tissue). The use a electron microscopy routinely to assess purity is acknowl-
edged to be difficult28• The procedures most commonly used for the embed-
ding of islets require sedimentation, and the pellet that is fonned generally 
does not contain randomly distributed cells. In addition, the frequency of islet 
or non-islet tissue may depend upon what part of the block was assessed. 
Viability assays - Viability assays, at best, are indirect measures of cellular 
anabolic properties such as membrane integrity, nucleotide incorporation, 
and enzyme content; or catabolic properties such as respiratory quotient. 
Quantitative tests of pancreatic islet viability, including measurements of in-
sulin biosynthesis, insulin secretion, and respiration have typically been used 
in studies of basic islet physiology, pathology, and responses to phannacologic 
agents. Less elegant (but also less labor-intensive) tests of islet viability involve 
assessment of membrane penneability. However, such tests can be rapidly per-
fonned, an advantage if used to assess islet viability just prior to islet transplan-
tation. 
Chromogenic dyes such as neutral red (inclusion of dye by live cells) or 
trypan blue (exclusion of dye by live cells) are of limited usefulness since live 
cells or dead cells can be visualized, but not both. The use of fluorometric 
inclusion and exclusion dyes together have been used to simultaneously quan-
titate the proportion of cells that are intact or that are damaged. For example, 
fluorescein diacetate (FDA), a nonpolar ester, freely passes through the cell 
membrane of live cells. Within the live cell it is ultimately hydrolyzed to the 
polar free fluorescein, where it is trapped within the intact membrane 12. Acri-
dine orange, a monovalent, cationic dye, is also membrane penneable. It 
binds to nucleic acids, and in low concentration causes a green fluorescence 
in living cells. The exclusion dyes propidium iodide, or the parent analog 
ethidium bromide, cannot penetrate living cells, but readily enter dead or dy-
ing cells. They intercalate with DNA or RNA and fonn bright red fluorescent 
complexes. 
The combination of inclusion and exclusion dyes acridine orange (AO) 
and propidium iodide (PI) have been extensively studied as an assay of islets 
viability5.6. The dyes have minimal background fluorescence, and when used 
in optimal concentrations 1 (AO - 0.67 fLmolll; PI - 75 fLmolll) stain living 
cells green and dead cells red. Utilizing this fluorometric method, viable and 
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non-viable whole islets may be differentiated, as well as viable and non-viable 
components within an islet. The stability, cytotoxicity and reproductivity of the 
assay has been demonstrated on isolated islets derived from mice, rats, dogs, 
and humans. 
In vitro studies - The isolation of large numbers of pure human islets is not 
the only consideration for successful transplantation studies. The isolation 
process itself may alter the functionality of the islets. It is thus crucial that the 
isolated islets be shown not only to be viable but also able to respond approp-
riately to glucose stimulation. Tn vitro biochemical techniques have predomi-
nantly been used to assess islet viability. Measurement of insulin release from 
islets after stimulation with different concentrations of glucose has commonly 
been used in static incubations2, 3, 4, 11 or in a continuous system by 'perifu-
sion' 16, 30, 34, 37. Glucose utilization 3, protein (insulin) synthesis 14,34 and oxygen 
utilization 34 have also been used to assess vital islet functions. 
Perifusion of islets with glucose provides a dynamic profIle of the charac-
teristics of glucose-mediated insulin release from pre-stored and newly-syn-
thesized insulin and of the ability of the cells to down regulate insulin secre-
tion after the glycemic challenge is interrupted45. The results of perifusion of 
large mammal or human islets depend upon many factors. Factors affecting 
the dynamic secretion of insulin by isolated islets are the procurement tech-
nique for the pancreas, including the nature of the preservation solutions, 
the duration of hypothermic storage 44 and the properties of the gradient 
materials used during islet purifIcation (step with Percoll or Ficoll)29. The size 
of the islets selected also influences the quantity of insulin secreted per 
islet24• A preliminary period of tissue culture following isolation or cryopres-
ervation can stabilize basal insulin release 17, 26. All of these factors should be 
reported in studies that use perifusion as an index of islet viability. Perifusion 
protocols which yield consistent results are based upon a method reported by 
LACY et a1. 16 in 1976. Duplicate groups of 200-300 islets of comparable size are 
transferred to millipore chambers and suspended on a fIlter of 5.0 [Lm. The 
chambers are closed, care being taken to exclude all air. They are inserted 
into an incubator at 37°C connected to a pump that delivers perfusate at 1.0 
mllmin and PE50 outflow tubing that passes to collection vials which rotate 
on a fraction collector. The perfusate is Krebs-Ringer bicarbonate solution 
which is maintained at 37°C and gassed with 95% °2:5% CO2, The perfusate 
is pumped through the chambers for three consecutive hours, during which 
the glucose concentration is 50, 500 and 50 mg/ dl, respectively. The effluent 
from the chamber is sampled every 10 min after subjecting the islets to peri-
fusion for 40 min to eliminate an artifactual rise in insulin due to mechanical 
stimulation from the transfer procedure. During the second hour, samples 
are removed at 1, 2.5, 5, 7.5, 10,20,30,40,50 and 60 min, and during the fmal 
hour every 10 min. The samples are collected at 4 °C and stored at -20°C 
until assay for insulin using a double antibody radioimmunoassay tech-
nique9. 
Standards for reporting results of perifusion data are critical for the accu-
rate comparison of data. The minimum values that should be reported are the 
absolute levels of insulin secretion during the pre-challenge basal period, the 
fIrSt 10 min (fIrst phase) and last 50 min (second phase) of high glucose chal-
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lenge, and the last 30 min after return to low glucose. The profIle of insulin 
release is best reported as a plot that shows the release during the three con-
secutive periods. An acceptable way of interpreting data would be to report 
'stimulation indices'44 estimated by determining the ratio between basal (last 
15 min before high glucose and last 15 min after return to basal conditions) 
and stimulated insulin release (fIrst 15 min and last 15 min of stimulation). 
This method of reporting identifIes the secretory capacity but lacks details of 
basal insulin release, the quality of the biphasic response and return to basal 
secretion, it should not, therefore, be reported alone. For convenience of com-
parison of insulin release data from various protocols within a given study, 
secretion can be assessed independently of basal secretion values by subtract-
ing mean pre-challenge basal levels from the remaining values to show the 
incremental insulin secretion 29. 
Although perifusion data provides a useful guide to islet viability, the quan-
tity and kinetics of insulin release do not necessarily predict islet performance 
after implantation. For example, rodent islets cryopreserved with slow cooling 
and thawed with slow warming showed a similar peri fusion response to islets 
cooled slowly and thawed rapidly, but the former did not reverse streptozo-
tocin diabetes 24. Similarly, frozen-thawed purifIed canine islets failed to secrete 
insulin during perifusion, but they consistently induced normoglycemia after 
autoimplantation into the spleen of pancreatectomized recipients 10. Therefore, 
the ultimate test of viability is functional activity after transplantation into a 
diabetic recipient. This tests not only insulin secretory capacity, but also viabil-
ity that allows the islet to withstand the rigors of engraftment in an ectopic site 
of a diabetic recipient until revascularization is complete. 
In vivo studies - Attempts have been made to ascertain human islet viability 
in vivo by transplantation into a specifIc animal model, the nude (athymic) 
rodent. These animals have a defICient immune system due to congenital 
thymic aplasia and are unable to reject transplanted xenogeneic tissue 24. The 
first report of transplantation of human pancreatic tissue into the nude ro-
dent was by POVLSEN et al,27 in 1974, when several portions of human fetal 
pancreas were transplanted subcutaneously into a non-diabetic nude mouse. 
Histological examination of the excised tissue at 64 days post-transplantation 
revealed a relatively normal lobular appearance with no sign of rejection. A 
number of groups subsequently reported further success with transplanta-
tion of human fetal pancreas into the non-diabetic nude mouse with obser-
vation of histological differentiation and the maturation of endocrine 
tissue 10, 22, 27, 42. 
Viable insulin containing tissue with no sign of rejection was also demon-
strated histologically, at 2 weeks post-implantation, in four survivors out of 15 
non-diabetic nude mice transplanted with freshly isolated human adult islets 
by GRAY et al. ll and more recently, in the nude rat, with cryopreserved human 
islets 43. Although these reports indicated the potential value of this animal 
model for xenotransplant studies, the assessment of the functional ability of 
transplanted tissue is only possible in diabetic recipients. 
BUSCHARD et al. 8 were the fIrst to report reversal of streptozotocin-induced 
diabetes in 3 out of 6 nude mice transplanted subcutaneously with 1-3 neona-
tal rat whole pancreas grafts. Blood glucose returned to normal 2 weeks after 
191 
HUMAN ISLET ISOLATION ASSESSMENT 
transplantation and the animals survived and gained weight for 27-93 days. 
Intraperitoneal transplantation of isolated human islets (2 cases) and allo-
geneous mouse islets (4 successes out of 8 transplants) into diabetic nude 
mouse was subsequently reported 23.34. As indicated above the criteria for suc-
cess was a reduction in blood glucose over a period of time. Glucose levels did 
not, however, return to normal and there was no confIrmation of graft func-
tion by glucose tolerance testing, reversal to the diabetic state following graft 
removal or histological confirmation of graft survival. The maturation of hu-
man fetal pancreas in diabetic nude mouse recipients, including one case of 
reversal of diabetes, has also been demonstrated 41. Graft function at 52 weeks 
post-transplantation in the normoglycemic animal was confIrmed by recur-
rence of diabetes on graft removal. The relative paucity of reports on pancreas 
transplantation in the diabetic nude rodent, probably reflects the poor survival 
of such animals not only in their normal immunologically incompetent state 
but also after induction of diabetes. 
More recently, studies have shown that isolated human islets can success-
fully reverse diabetes in the nude rodent. RICORDI et al,3I,33 utilized the nude 
mouse, made diabetic with streptozotocin, and demonstrated long-term rever-
sal of the blood glucose following transplantation of fresh, cultured and cryo-
preserved human islets. 
In addition, LAKE et al. 18,19 using the nude rat and a specifICally developed 
model with a very short (2-day) diabetic induction period, were able to rapidly 
reverse the diabetic state with 2-day cultured human islets. Furthermore, the 
engrafted islets in the normoglycemic recipients responded appropriately to a 
glucose challenge. The failure of aliquots of islets from a particular pancreas 
to reverse the diabetic state was of interest and both research groups believe 
that the diabetic nude rodent model offers a relatively simple method of test-
ing the in vivo functional state of human islet preparations. 
SUMMARY 
Recent progress in islet isolation from the pancreas of large mammals including man, 
accentuated the need for the development of precise and reproducible techniques to assess islet 
yield. In this report both quantitative and qualitative criteria for islet isolation assessment were 
discussed, the main topics being the determination of number, volume, purity, morphologic 
integrity and in vitro and in vivo function tests of the fmal islet preparations. It has been 
recommended that dithizone should be used as a specific stain for immediate detection of islet 
tissue making it possible to estimate both the total number of islets (dividing them into classes 
of 50 fl. diameter range increments) and the purity of the fmal preparation. Appropriate mor-
phological assessment should include confirmation of islet identifICation, assessment of the 
morphological integrity and of the purity of the islet preparation. The use of fluorometric 
inclusion and exclusion dyes together have been suggested as a viability assay to simultaneously 
quantitate the proportion of cells that are intact or damaged. Perifusion of islets with glucose 
provides a dynamic profile of glucose-mediated insulin release and of the ability of the cells to 
down regulate insulin secretion after the glycemic challenge is interrupted. Although perifusion 
data provides a useful guide to islet viability the quantity and kinetics of insulin release do not 
necessarily predict islet performance after implantation. Therefore, the ultimate test of islet 
viability is their function after transplantation into a diabetic recipient. For this reason, in vivo 
models of transplantation of an aliquot of the fmal islet preparation into diabetic nude 
(athymic) rodents have been suggested. We hope that these general guidelines will be of assist-
ance to standardize the assessment of islet isolations, making it possible to better interpret and 
compare procedures from different centers. 
192 
C. RICORDI et al. 
REFERENCES 
1. ALEJANDRO R., CUTFIELD R. G., SHIENVOLD F. L., POLONSKY K. S., NOEL]', OLSON 1.., LIlLBERGER 
]., MILLER]., MINTZ D. H.: Natural history of intrahepatic canine islet cell autografts -]. din. 
Invest. 78, 1339-1348, 1986. 
2. A:-IDERSSON A., BORG H., GROTH C. G., GU:-INARSSON R., HELLERSTROM C., LUNDGREN C., WEST-
MAN]., OS1MAN].: Survival of isolated human islets of Langerhans maintained in tissue cul-
ture -]. clin. Invest. 57, 1295-1301, 1976. 
3. AsHCROFT S.]. H., BASSETT]' M., RANDLE P.].: Isolation of human pancreatic islets capable of 
releasing insulin and metabolizing glucose in vitro - Lancet i, 888-889, 1971. 
4. BALLINGER W. F., LACY P. E.: Transplantation of intact pancreatic islets in rats - Surgery 72, 
175-186, 1972. 
5. BANK H. 1..: Assessment of islet cell viability using fluorescent dyes - Diabetologia 30, 812-817, 
1987. 
6. BANK H. 1,,: Rapid assessment of islet cell viability with acridine orange and propidium io-
dide - In Vitro 24,266-272, 1988. 
7. BRF.LJE T. C., SHARP D. W., SORENSON R. 1..: Three-dimensional imaging of intact isolated 
islets of Langerhans with cofocal microscopy - Diabetes 38, 808-814, 1989. 
8. BUSCHARD K., RYGAARD].: Restitution of streptozotocin induced diabetes mellitus in nude 
mice with pancreatic graft from the rat - Acta path. microbiol. scand. (Sect. C) 84, 221-226, 
1976. 
9. EVANS M. G., RAJOTTE R. v., WARNOCK G. 1.., KNETEMAN N. M.: Viability studies of cryopre-
served isolated canine islets of Langerhans - Trans. Proc. 21, 3368-3370, 1989. 
10. FESTING M. F. W.: Athymic nude rats. Ill: GERSHWIN E., MERCHANT It (Eds): Immunological 
Defects in Laboratory Animals. Vol. 1. Plenum Co., 1981; pp. 12-24. 
11. GRAY D. W. R., MCSHANE P., GRANT A., MORRIS P.].: A method for isolation of islets of Langer-
hans from the human pancreas - Diabetes 33, 1055-1061, 1984. 
12. GRAY D. W. R., MORRIS P.].: The use of fluorescein diacetate and etheidum bromide as a 
viability stain for isolated islets of Langerhans - Stain. Techno!. 62, 379-381, 1987. 
13. HEDESKOV C. j.: Mechanism of glucose-induces insulin secretion - Physio\. Rev. 60, 442-509, 
1980. 
14. KNETEMAN N. M., RAJOTTE R. v.: Isolation and cryopreservation of human pancreatic islets -
Trans. Proc. 18, 182-185, 1986. 
15. LACY P. E.: Beta cell secretion - from the standpoint of a pathobiologist - Diabetes 19, 895-
905, 1970. 
16. LACY P. E., FINKE E. H., CONANT S., NABER S.: Long-term perfusion of isolated rat islets in 
vitro - Diabetes 25, 484-493, 1976. 
17. LACY P. E., KOSTIANOVSKY M.: Method for the isolation of intact islets of Langerhans from the 
rat pancreas - Diabetes 16, 35-39, 1967. 
18. LAKE S. P., CHAMBERLAIN J., BASSETT P. D., LONDO!'.: N. j., WALCZAK K., BELL 1'. R. F., JAMES 
R. F. L.: Successful reversal of diabetes in nude rats by transplantation of isolated adult hu-
man islets of Langerhans - Diabetes 38,146-151,1989. 
19. LAKE S. P., CHAMBERLAIN J, HUSKEN P., BELL P. R. F., JAMES R. F. 1..: In vivo assessment of 
isolated pancreatic viability llsing the streptozotocin-induced diabetic nude rat - Diabetologia 
31, 390-394, 1988. 
20. LATIF Z. A., NOEL]', ALEJANDRO R.: A simple method of staining fresh and cultured islets -
Transplantation 45, 827-830, 1988. 
21. LUNDGREN G., ANDERSSON A., BORG H., BUSCHARD K., GROTH C. G., GUNNARSSON R., HELLER-
STROM c., PETERSSON B., OSTMAN J.: Structural and functional integrity of human islets of 
Langerhans maintained in tissue culture for 1-3 weeks - Trans. Proc 19,237-240, 1977. 
193 
---------- --------------------------
HUMAN ISLET ISOLATION ASSESSMENT 
22. MANDEL T. E_, GEORGIOU H. M.: Xenotransplantation of human fetal islets in nude mice -
Trans. Proe. 16, 849-850, 1984. 
23. MILLARD P. R., REECE-SMITH H., SMART Y. C, MCSHANE P., MORRIS F J: Observations on rat 
collagenase-separated islets and long-term composite islet allografts - Brit. J expo Patho!' 65, 
745-751, 1984. 
24. MORGAN C. R., LAZAROW A.: Immunoassay of insulin: antibody system_ Plasma insulin levels 
of normal, subdiabetic and diabetic rats - Diabetes 12, 115-126, 1963. 
25. MOSKALEWSKI S.: Isolation and culture of islet of Langerhans of the guinea pig - Gen. compo 
Endocrino!. 5, 342-353, 1985. 
26. I'ETKOV P., HAHN R J, GALABOVA R., ZIELGER M.: Investigations on islets of Langerhans in 
vitro. Ultrastructure and insulin secretion of isolated rat islets after different digestion with 
collagenase - Acta histochem. (Jena) 51, 50-60, 1984. 
27. POVLSEN C. 0., SKAKKEBAEK N. E., RYGAARD J, JENSEN G.: Heterotransplantation of human 
foetal organs to the mouse mutant nude - Nature (Lond_) 248, 247-249, 1974. 
28. PRETLOW II T. G., PRETLOW T. P.: Evaluation of data, problems, and general approach. In: 
PRETLOW II T. G., PRETLOW T. P. (Eds): Cell Separation: Methods and Selected Applications. 
Vol 1. Academic Press, New York, London, 1982; pp. 31-40. 
29_ RAJOTTE R. V., WARNOCK G. L., KNETEMAN N. M., ERICKSON C., ELLIS D_: Optimizing cryopreser-
vation of isolated islets - Trans. Proe. 21, 2638-2640, 1989. 
30. RICORD! C., FINKE E. H., LACY P. E.: A method for the mass isolation of islets from the adult 
pig pancreas - Diabetes 35, 649-653, 1986. 
31. RICORDI C, KNETEMAN N. M., SCHARP D. W., LACY P. E.: Transplantation of cryopreserved 
human pancreatic islets into diabetic nude mice - WorldJ Surgery 12, 861-864,1988. 
32. RICORDI C., LACY P_ E., FINKE E. H., OLACK B. j., SCHARP D. W_: Automated method for isola-
tion of human pancreatic islets - Diabetes 37, 413-420, 1988. 
:13. RICORDI C., SCHARP D. W., LACY P. E.: Reversal of diabetes in nude mouse after transplanta-
tion of fresh and 7-day cultured (24 degrees C) human pancreatic islets - Transplantation 45, 
994-996, 1988. 
34. SCHARP D. W., LAcy P. E., FINKE E., OLACK B.: Low temperature culture of human islets iso-
lated by the distension method and purified with Ficoll and Percoll gradients - Surgery 102, 
869-879, 1987. 
;35_ SCHWARTZ B. D., TRAVERSO W.: Morphological changes in pancreatic fragments prepared for 
transplantation by collagenase treatment - Transplantation 38,273-280, 1984. 
36. SCHWEDES u., KAUL S., WDOWINSKIj., KLEMPA I., BASTERT G., USADEL K. H.: The use of human 
fetal pancreas for transplantation: experimental and clinical results - Hormone metabol. Res. 
13,87-90, 1983_ 
37_ SUTHERLAND D. E_ R_, MATAS A. j., STEFFES M. W., NAJARIAN J S.: Infant human pancreas: a 
potential source of islet tissue for transplantation - Diabetes 25, 1123-1128, 1976. 
38. SUTHERLAND D. E. R., STEFFES M. W., BAUER G_ E., McMANUS D_, NOE B. P., N,yARIAN j. S_: 
Isolation of human and porcine islets of Langerhans and islet transplantation in pigs -
j. surg. Res. 16, 102-111, 1974. 
39. SYED Au S., SYED Au M. M., HERING B. J, BRETZEL R. G., FEDERLIN K.: Morphological studies 
on bovine islets isolated by digestion filtration - Cell Tiss. Res. (In press). 
40. TUCH B. E., JONES A., TURTLE j. R.: Maturation of response to human fetal pancreatic ex-
plants to glucose - Diabetologia 28,28-31, 1985_ 
41. TlJCH B. E., NG A. B. P_, JONES A., TURTLE j. R.: Histologic differentiation of human fetal 
pancreatic explants transplanted into nude mice - Diabetes 33, 1180-1187, 1984. 
42. USADEL K. H., SCHWEDES u., BASTERT G., STEINAU u., KLEMPA I., FASSBINDER W., SCHOFFLING K_: 
Transplantation of human fetal pancreas. Experience in thymus aplastic mice and rats and 
in a diabetic patient - Diabetes 29 (Supp!. I), 74-79, 1980. 
194 
C. RICORDI e1. aI. 
43. WARNOCK G. L., GRAY D. W. R., MCSHANE P., PETERS M., MORRIS P. J.: Survival of cryopreserved 
isolated adult human pancreatic islets of Langerhans - Transplantation 44, 75-82, 1987. 
44. tA~DyllCh G. L., ELLIS D., RAJOTTE R. v., DAWTDSON 1., BAEKKESKOV S., EDEBJERG J.: Studies of 
the isolation and viability of human islets of Langerhans - Transplantation 45, 957-963, 1988. 
45. WAR:-IOCK G. L., R>\jOTTE R. v., EVANS M.G., ELLIS D. K., DEGROOT 1'., DAWTDSON I.: Isolation of 
islets of Langerhans following cold storage of human pancreas - Trans. Proc. 19, :1466-3468, 
1987. 
46. ZIMNY M. L., BlACKARD W. G.: The surface of isolated pancreatic islet cells - Cell Tiss. Res. 
164,467-471, 1975. 
Requests for reprints should be addressed to: 
CAMIlLO RICORD! 
Department of Surgery 
3601 Fifth Avenue 
Falk Clinic 4 West 
Pittsburgh, Pennsylvania 15213 - U.S.A 
195 
